Link workers providing social prescribing and health and social care coordination for  people with multimorbidity in socially deprived areas (the LinkMM trial): protocol for  a pragmatic randomised controlled trial by Kiely, Bridget et al.
1Kiely B, et al. BMJ Open 2021;11:e041809. doi:10.1136/bmjopen-2020-041809
Open access 
Link workers providing social 
prescribing and health and social care 
coordination for people with 
multimorbidity in socially deprived 
areas (the LinkMM trial): protocol for a 
pragmatic randomised controlled trial
Bridget Kiely,1 Barbara Clyne   ,1 Fiona Boland   ,1 Patrick O'Donnell,2 
Deirdre Connolly,3 Eamon O'Shea,4 Susan M Smith   1
To cite: Kiely B, Clyne B, 
Boland F, et al.  Link workers 
providing social prescribing 
and health and social care 
coordination for people 
with multimorbidity in 
socially deprived areas (the 
LinkMM trial): protocol for 
a pragmatic randomised 
controlled trial. BMJ Open 
2021;11:e041809. doi:10.1136/
bmjopen-2020-041809
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
041809).
Received 17 June 2020
Revised 01 December 2020
Accepted 07 December 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Bridget Kiely;  
 bridgetkiely@ rcsi. com
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction Link workers are non- health or social care 
professionals based in primary care who support people 
to develop and achieve a personalised set of health and 
social goals by engaging with community resources. 
Link workers have been piloted in areas of deprivation, 
but there remains insufficient evidence to support their 
effectiveness. Multimorbidity is increasing in prevalence, 
but there are limited evidence- based interventions. 
This paper presents the protocol for a randomised 
controlled trial (RCT) that will test the effectiveness 
of link workers based in general practices in deprived 
areas in improving health outcomes for people with 
multimorbidity.
Methods and analysis The protocol presents 
the proposed pragmatic RCT, involving 10 general 
practitioner (GP) practices and 600 patients. Eligible 
participants will be community dwelling adults with 
multimorbidity (≥two chronic conditions) identified 
as being suitable for referral to a practice- based link 
worker. Following baseline data collection, the patients 
will be randomised into intervention group that will 
meet the link worker over a1- month period, or a ‘wait 
list’ control that will receive usual GP care. Primary 
outcomes are health- related quality of life as assessed 
by EQ- 5D- 5L and mental health assessed by Hospital 
Anxiety and Depression Scale. Secondary outcomes 
are based on the core outcome set for multimorbidity. 
Data will be collected at baseline and on intervention 
completion at 1 month using questionnaires self- 
completed by participants and GP records. Parallel 
process and economic analyses will be conducted to 
explore participants’ experiences and examine cost- 
effectiveness of the link worker intervention.
Ethics and dissemination Ethical approval has been 
granted by the Irish College of General Practitioners 
Ethics Committee. The findings will be published in peer- 
reviewed journals.
Trial registration number ISRCTN10287737;
Pre- results.
INTRODUCTION
Multimorbidity, defined as the presence of 
two or more chronic conditions, is recognised 
as a significant challenge for patients and 
healthcare systems, particularly in primary 
care and in areas of social deprivation.1 
Within the broader multimorbidity popula-
tion, there are people with higher numbers 
of conditions involving multiple body systems 
with related polypharmacy, which is referred 
to as complex multimorbidity.2 Multimor-
bidity and complex multimorbidity are esti-
mated to affect 66.2% and 11%, respectively, 
Strengths and limitations of this study
 ► The LinkMM study is a pragmatic randomised 
controlled trial examining the effectiveness of a 
practice- based link worker intervention for people 
with multimorbidity.
 ► The focus on people with multimorbidity builds the 
evidence base for generic interventions that work 
across all conditions in multimorbidity.
 ► The short intervention and follow- up period allows 
for a wait list control design and is consistent with 
the duration of real world link worker interventions, 
but may be too short to show a meaningful differ-
ence in outcomes.
 ► There is large number of patient- reported outcomes, 
consistent with the Medical Research Council guid-
ance on evaluating complex interventions, but this 
may be off- putting to people with lower literacy 
levels, creating challenges for recruitment and po-
tential threats to generalisability for very vulnerable 
adults with multimorbidity.
 ► Parallel process and economic analysis will add to 
our understanding of the implementation of this type 
of intervention and determine the cost- effectiveness 
of the intervention.
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of people over 50 years of age attending Irish General 
Practice.3 Complex multimorbidity is associated with 
increased healthcare utilisation and costs. People with 
complex multimorbidity experience fragmented care, 
poorer mental health and have worse outcomes.4 5 There 
are higher proportions of patients with complex combina-
tions of physical and mental health conditions in deprived 
areas.4 This is reflected in higher consultation rates and 
has ramifications throughout the health system. A total 
of 10% of patients with 4 or more conditions account 
for 34% of unplanned emergency admissions and 47% 
of preventable unplanned admissions.6 People living in 
deprived areas develop multimorbidity 11 years earlier4 
and experience worse quality of life compared with those 
with multimorbidity in less deprived areas.7 It is not clear 
why this is, but there is growing evidence that people with 
multimorbidity in areas of deprivation have reduced self- 
efficacy and capacity for self- management due to psycho-
social stressors, poorer mental health, increased burden 
of treatment and lower perceived social support.8–13
There is as yet, limited evidence to indicate which inter-
ventions for multimorbidity have a significant impact 
on health outcomes or health service utilisation.14 One 
potential intervention to address the complex mix of 
psychosocial issues and multimorbidity in areas of depri-
vation is the use of link workers in primary care. A link 
worker is a non- health or social care professional who 
usually has training in coaching or behaviour change, 
as well as an extensive knowledge of local community 
resources. They work with people referred to them by 
healthcare services to identify their health and social 
care needs, and support them to access services within 
the community to improve their health and well- being, a 
process commonly referred to as social prescribing.15 The 
Glasgow Deep End Links Worker programme describes 
the principle behind the link worker intervention as ‘a 
catalyst to hope and self- determination, using the strong 
relationships with patients that exist in general prac-
tice. If patients with complex needs feel supported, they 
would be more likely to respond to information on ways 
to improve their health’. The current study builds on 
this work using a similar intervention approach with link 
workers embedded in practices in deprived urban areas.
Although link workers providing social prescribing have 
been gaining popularity in the UK and there have been 
a number of pilots in Ireland,16 17 few have been formally 
evaluated. A recent review of link worker provided social 
prescribing in the UK found limited evidence to support 
the effectiveness and concluded that there was a lack of 
evidence for how, for whom and when social prescribing 
was effective.18 A recent quasi- experimental evaluation of 
the Glasgow Deep End Links Worker programme found 
some impact on mental health scores for patients and 
staff morale in general practitioner (GP) practices and 
concluded that larger, longer studies with randomisation 
at the individual patient level were needed.19
The Deep End Ireland GP group, a network of prac-
tices based in areas of deprivation, prepared a report on 
link worker provided social prescribing in Ireland that 
outlined its potential to address the psychosocial burden 
faced by their patients and the impacts of upstream social 
determinants of heath that GPs often encounter, but can 
have little impact on in practice.20
To inform the implementation of the intervention and 
evaluation processes a short uncontrolled pilot study 
was conducted in one practice with 12 patients. This 
confirmed the feasibility of intervention delivery and led 
to refinements in patient selection and data collection 
processes (paper in submission process with the Journal 
of Comorbidity).
This study aims to evaluate a link worker intervention in 
primary care on health outcomes for people with complex 
multimorbidity in socially deprived areas. Secondary aims 
are to examine the impact on staff morale and conduct 
a mixed methods process evaluation and economic eval-
uation of the intervention, exploring direct and indirect 
costs.
METHODS
This protocol is presented using the Standard Protocol 
Items: Recommendations for Interventional Trials recom-
mendations for the reporting of a protocol for an inter-
ventional trial.21
Study design
This will be a pragmatic randomised controlled trial 
(RCT) to evaluate a link worker intervention in 
improving health outcomes for people with multimor-
bidity attending primary care in socially deprived areas 
compared with wait list controls who receive usual care. 
It will be reported in accordance with the Consolidated 
Standards of Reporting Trials guidance for RCTs.22 The 
economic analysis will be a cost utility analysis from the 
perspective of the public healthcare system and will be 
carried out in accordance with the guidance produced by 
the Health and Information Quality Authority Ireland.23
A parallel mixed methods process evaluation will be 
conducted in line with the Medical Research Council 
(MRC) guidance on evaluating complex interventions.24 
The process evaluation protocol will be informed by the 
MRC framework for process evaluations.25 A full protocol 
for the process evaluation will be published in an open 
access source.
Public and patient involvement
This study has public and patient involvement (PPI) 
through a multimorbidity patient advisory group. The 
patient advisory group are patients with multimorbidity 
who meet quarterly to discuss issues arising with research 
projects on multimorbidity funded through the Health 
Research Board Collaborative Doctoral Award (BK is 
a PhD student on this programme). The specific input 
of the PPI groups is outlined in the pilot study paper 
(paper in submission process with the Journal of Comor-
bidity) but, in summary, it included co- design of patient 
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information leaflets, input on patient outcome selection 
and questionnaire design.
Implementation advisory group
The implementation advisory group consists of GPs 
working in deprived areas, with and without experience 
of social prescribing and a project manager from a well- 
established social prescribing project in a deprived inner 
city area in Dublin, Ireland.
Study settings
This study will be conducted in urban general practices 
serving areas of deprivation in four cities (Dublin, Cork, 
Limerick and Waterford) in Ireland. Serving areas of 
deprivation will be defined as providing general practice 
care to at least two small areas identified as disadvan-
taged or below by the Pobal HP Deprivation Index and 
providing services to at least 1000 patients under the 
General Medical Services (GMS) scheme. The Pobal HP 
Deprivation Index is Ireland’s most widely used social 
gradient metric and scores each small area (50–200 
households) in terms of affluence or disadvantage. The 
index uses information from Ireland’s census, such as 
employment, age profile and educational attainment, to 
calculate this score.26 The GMS scheme provides medical 
care to approximately 40% of the Irish population. It 
is predominantly means- tested and provides eligible 
patients with free GP visits, free hospital care and free 
medications (except for a prescription levy, currently 
€2.50 for every item to a maximum of €25).
Eligibility criteria
Participants
Participants will be community dwelling adults aged over 
18, who have two or more chronic conditions (multimor-
bidity), attend a GP who provides care for patients living 
in an area of deprivation and have been identified by 
their GP as having potential to benefit from a link worker 
intervention. As this is a pragmatic trial, we are seeking 
to replicate conditions in real work practice where GPs 
would refer to a link worker based on need. There will 
be no predefined conditions, other than the conditions 
should be chronic, that is lasting or expected to last more 
than 6 months.
Exclusion criteria include psychiatric/psychological 
morbidity or cognitive impairment that would impair 
capacity for informed consent, a terminal illness likely 
to lead to death or major disability during the study 
follow- up period, living in residential care, already partic-
ipating in a similar programme or had previously partici-
pated in the pilot study.
Practices
Ten practices in the Deep End Ireland group will be 
invited to participate.27 Membership of the group is open 
to any practice that identifies as working in an area of 
deprivation. In addition, practices must have a GMS list 
of >1000 patients, serve at least two small areas defined 
as disadvantaged or below by the Pobal HP Deprivation 
Index 2016 and have space to host a link worker on site. 
Practices that are taking part in another link worker 
project will be excluded.
Recruitment and randomisation
Each practice will be asked to recruit 60 participants, 
giving a total of 600 patients. Recruitment will begin 
1 month before the start date of the intervention and will 
be phased for logistical reasons with 20 participants being 
recruited each month in each practice.
Eligible participants will be identified by their GPs, 
based on being prescribed five or more medications 
as a proxy for multimorbidity. This proxy is being used 
because of significant variation in coding practices for 
chronic conditions in Ireland and lack of a code for multi-
morbidity. A finder tool in the electronic record, previ-
ously developed for another multimorbidity study,28 will 
generate this list of patients. Previous research has indi-
cated that medication count is a suitable proxy measure 
for multimorbidity.6 The GP team will screen this list of 
patients with multimorbidity to identify all patients who 
they would refer to a link worker and thus create a register 
of potentially eligible patients. This process is based on 
our pilot study findings and is designed to reflect real- 
world conditions where GPs refer patients they identify 
as having a psychosocial need that would benefit from a 
social prescribing approach to a link worker. Once this 
register of potentially eligible patients is created, GPs will 
be supported to arrange the list in random order and 
select the first 30 potential participants to invite. They will 
then be asked to double check that the selected partici-
pants meet the inclusion criteria and ensure none of the 
exclusion criteria apply. GPs will also be asked to docu-
ment the reasons why each of the selected patients would 
be referred to a link worker using a standardised list of 
options. This list will include reasons for referral identi-
fied from other studies and known proxies for psychoso-
cial need, such as frequent attendance and will also allow 
GPs to record free text additional reasons. This process 
will improve transparency around referral decision 
making and provide additional data on types of patients 
referred for link worker supports and is summarised in 
figure 1.
The research team will update the GP practices on a fort-
nightly basis of who has returned consent forms. The GPs 
will be encouraged to remind anyone who had verbally 
agreed to take part during the phone call stage, but not 
yet returned a consent form to do so. At monthly intervals, 
the GPs will be asked to invite another 30 patients from 
the randomly ordered list of potential participants until 
the total of 60 participants has been reached. Recruitment 
will end 10 weeks before the end of the study to allow 
for sufficient time for baseline data collection, rando-
misation and delivery of the intervention. The expected 
recruitment rate is 60% based on the quasi- experimental 
evaluation of the Glasgow Links Worker project19 where 
50% of potential participants were recruited and our own 
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pilot where 70% of invited participants returned consent 
and baseline questionnaires.
A letter of invitation, patient information leaflet, and 
consent and baseline questionnaires will be sent to eligible 
participants and GP teams will follow- up with phone calls 
to explain the study and see if potential participants 
require assistance completing the baseline question-
naires. One in six Irish adults are functionally illiterate29 
and so it is assumed that at least this number will require 
their GP to verbally explain the study and need assistance 
with completion of the baseline questionnaires. Once 
they have consented, a member of the research team can 
assist them with baseline data collection either face to 
face at the practice or over the phone.
Randomisation will take place following baseline data 
collection to avoid allocation bias. Randomisation will 
be carried out by an independent researcher and over-
seen by the trial statistician using a computer- generated 
sequence. Patients will be stratified by practice and age, 
and allocation will be blocked using random permuted 
blocks of sizes two and four to ensure balanced numbers 
of intervention and control patients in each practice.
The independent researcher will inform the research 
team of allocations. The research team will contact the 
participants by phone to inform them of their allocation 
and what to expect. The research team will inform the 
relevant link worker by phone who has been allocated to 
the intervention group. A letter will be sent to the GP 
practice informing them of the participants involvement 
in the trial and their allocation. Due to the nature of the 
intervention, it is not possible to blind participants, link 
workers or GPs to the allocation. Blinding will be imple-
mented at the data analysis stage.
Intervention
The link worker intervention (LinkMM) is based on the 
Glasgow Deep End Links Worker project which had a 
quasi- experimental cluster design.30 Our intervention 
is shorter than the Glasgow project to facilitate the wait 
list control study design and it does not include practice 
subsidies for developing in- practice activities beyond 
hosting the link worker. The LinkMM is a complex inter-
vention with the following components:
 ► Link worker training and support.
 ► GP training.
 ► Compilation and mapping of local health and social 
care community resources.
 ► Link worker participant meetings and follow- up.
 ► Financial supports to practices.
Link worker training and support
To inform the implementation of link worker social 
prescribing project, the lead researcher attended Social 
Prescribing Network Ireland meetings and engaged with 
local social prescribing projects to explore the nature of 
the link worker role and appropriate job specifications, 
training, communication with GPs and engaging with 
community resource providers. In keeping with the liter-
ature, empathy and an ability to listen were identified as 
important link worker skills.31 Given the limited training 
time available, a background in health or social care and 
experience of working with disadvantaged communities 
were essential criteria for applicants to the role.
Resources from the Alliance website32 (the community 
organisation who had delivered the link worker interven-
tion in the Glasgow Deep End Links Worker project) were 
referenced to develop a 40- hour training plan with input 
Figure 1 Process for selection and recruitment of participants. GP, general practitioner.
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from local social prescribing providers and based on the 
experience of our pilot study link worker, who had signif-
icant experience in health and social care, and working 
with disadvantaged communities. Link workers will be 
employees of the research host institution rather than the 
general practices and will be line managed by the trial 
project manager. They will have monthly check- ins with 
the project manager and bimonthly peer support meet-
ings and review sessions. Any clinical concerns regarding 
participants will be raised with the individual’s GP. If for 
whatever reason they are unable to access the individu-
al’s GP, link workers can seek support from the principal 
investigator (SMS), an experienced GP.
GP training
GP practices will receive training on site or via video link 
on trial processes including selection and recruitment 
processes and the potential reasons a patient might be 
referred to a link worker. The link worker role will be 
explained.
Compilation and mapping of local health and social care 
community resources
The research team will have identified some key local 
resources for each area in advance of the link worker 
taking up their post. The link workers will have allo-
cated time during their induction period to map out 
local resources using a template developed during the 
pilot study. This will, however, be an ongoing process 
depending on the needs of participants. In the context of 
the ongoing COVID-19 pandemic, online and individual 
resources will also be identified for those unable to attend 
group activities.
Link worker participants meetings and follow-up
Following randomisation, intervention group partici-
pants will be referred to the link worker straightaway 
and invited to meet with them at least once, with at least 
60 min scheduled for this initial appointment. At the 
initial meeting, the link worker will explain their role and 
explore the participants’ health and social care priori-
ties, and produce a joint plan to address these. This will 
include a range of activities and community resources 
that participants may choose to attend to improve their 
health and well- being. The link worker will offer to 
follow- up and support participants to implement their 
plan. It is expected that support will broadly fall into one 
of four categories, informational (supplying information 
on resources and directing to websites), instrumental 
(making an appointment on behalf of a participant 
or accompanying them to an appointment), appraisal 
(helping participants to makes changes using behaviour 
change techniques, such as motivational interviewing) or 
emotional (listening and encouraging when participants 
face challenges).33 As support is tailored to the needs of 
the individual, it will vary. All link worker activity will be 
captured in a specifically designed client management 
database, including details of the initial assessment, 
priority health and social issues, goals set, community 
resources referred to and attended, number of follow- ups 
and the type of support provided, as per the categories 
outlined above. This will be fully reported in a parallel 
process evaluation and briefly described in the main trial 
report. There will be no change to the participants usual 
clinical care. At the end of the intervention period, the 
link worker will provide a summary to the participant’s 
GP, outlining the plan and resources they accessed to 
help achieve it.
The link worker will be based in the GP’s practice and 
meetings with participants will primarily be in the GP’s 
practice. The link worker will be able to liaise with the GP 
of the participant should they have any specific concerns 
about an individual. Link workers will also share knowl-
edge on local community resources with GPs during 
monthly meetings with practice staff.
Financial supports to practices
Practices will receive a stipend to cover one session a week 
of GP’s time to allow for time spent on recruitment and 
supporting the link worker intervention. An additional 
grant will cover any room hire and equipment costs that 
the practice may incur as a result of hosting the link 
worker.
Control
The RCT will have a wait list control. During the 1- month 
intervention period, the control group will receive usual 
care from their GP. On completion of the intervention, 
the control group will be invited to a one- off meeting with 
the link worker, during which they will have an opportu-
nity to identify their needs and be provided with a list of 
suggested resources tailored to these.
OUTCOMES
A wide range of outcomes will be used to assess interven-
tion effectiveness and mechanism of action in line with the 
MRC framework for evaluating complex interventions.24 
Outcomes are based on the pilot study findings and on 
the Core Outcome Set for Multimorbidity research.34 In 
line with the National Institute for Health and Care Excel-
lence, an additional measure of capability and well- being, 
the ICEpop CAPability measure for Adults (ICE- CAP A)35 
will be used alongside the EQ- 5D- 5L to capture the wider 
social benefits to the individual that are expected with 
this type of intervention.
Primary outcomes
 ► Health- related quality of life (HRQoL) as measured 
by EQ- 5D- 5L.36




 ► Capability and well- being as measured by the ICE- CAP 
A.35
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 ► Activities of daily living as measured by the Frenchay 
Activities Index.38
 ► Self- management as measured by the Patient Activa-
tion Measure.39
 ► Burden of treatment as measured by Multimorbidity 
Treatment Burden Questionnaire.40
Healthcare utilisation
Data from primary care electronic health records in the 
previous month unless otherwise specified:
 ► Number of GP attendances.
 ► Number of practice nurse attendances.
 ► Number and type of regularly prescribed medications.
 ► Number of out- of- hours GP attendances.
 ► Number of emergency department attendances.
 ► Number of hospital admissions (emergency) and 
length of stay.
 ► Number of hospital outpatient visits.
Sample size
A sample size of 600 participants in total has been calcu-
lated based on our two primary outcomes. Using a HADS 
Anxiety score of 10.9, a SD of 5.1 and a minimally clini-
cally important difference of 1.5 (based on a similar Scot-
tish population);30 for 90% power with approximately 
20% loss to follow- up, 600 patients are needed. Similar 
calculations for HRQoL, using 0.316 SD units in EQ5D 
(based on a similar Scottish population)30, for 90% power 
and presuming approximately 20% loss to follow- up, we 
need a sample of 510 patients. We will recruit the larger 
number of 600 patients (300 in each study arm).
Data collection
Data collection will be at baseline prerandomisation and 
at 1 month from initial invitation to the intervention 
group to meet with the link worker. This will be prior to 
the control group meeting once with the link worker and 
receiving a truncated version of the intervention.
Patient reported outcome measures will be self- 
reported using standardised paper- based questionnaires, 
which will be posted to participants. Data on patient costs 
and community resources accessed, will be self- reported 
using a specifically designed questionnaire. A member of 
the research team will assist participants to fill in paper- 
based forms if there are literacy issues.
The healthcare utilisation data on GP visits, out- of- 
hours GP visits, prescribed medications and emergency 
department attendances will be extracted from health-
care records by a member of the research team.
On completion of the RCT, we also plan to conduct an 
observational study on all participants at 9 months from 
the intervention group receiving an invitation to meet 
with the link worker to examine changes in outcomes 
over this longer time period.
Data management
Paper questionnaires will be returned by post to the 
research team in the Department of General Prac-
tice, Royal College of Surgeons in Ireland, who will be 
responsible for manual data entry into predesigned 
excel spreadsheets. All participants will provide informed 
consent for the processing of their data. Data will be 
pseudonymised with the use of a unique study identifi-
cation code. All data will be stored in secure encrypted 
institutional network drives accessible only to named 
members of the research team. A comprehensive data 
management plan is in place, which had been reviewed 
by the trial steering committee (TSC).
A TSC comprising an independent chair and three 
other independent members, one of whom is a lay 
member representing the patient and public perspective, 
has been established and will oversee the progress of the 
trial and adherence to the study protocol.
Unintended consequences will be monitored during 
the trial using self- reporting by participants, reporting by 
link workers during planned supervision and reporting 
by GPs. GPs will receive instructions on how to report any 
adverse events on concerns they have to the trial manager 
during their training on the intervention. In addition, the 
trial manager will check in on a monthly basis with prac-
tices to get updates on any recruitment, implementation 
challenges and adverse events. Unintended consequences 
will also be explored as part of the process evaluation.
Planned statistical analysis
Descriptive statistics will be used to describe recruited 
participants and to investigate comparability of trial 
groups at baseline. For primary and secondary outcomes, 
the primary analyses will be ‘intention- to- treat’, including 
all randomised participants, all retained in the group 
to which they were allocated and using last observation 
carried forward for missing values. The primary analysis 
will be adjusted for baseline scores and stratification vari-
ables, age and practice. Subsequent models will adjust 
for multimorbidity severity. We will also conduct a per- 
protocol (PP) analysis. The PP population will consist 
of those randomised to the intervention group who met 
with the link worker at least once. We will also conduct 
preplanned subgroup analyses based on gender and age 
(above and below 65 years of age). All analyses will use 
appropriate (ie, linear or Poisson) regression models with 
results presented as point estimates (difference in means 
or incident rate ratios), 95% CIs and p values. Stata 15 will 
be used for all data analysis.41
ECONOMIC EVALUATION
The health economic evaluation will consist of a trial- 
based cost utility analysis of the proposed intervention. 
The evaluation will be undertaken in a manner consis-
tent with guidelines issued by the Health Information 
and Quality Authority in Ireland.23 Evidence collected on 
direct costs of the intervention from the trial, community 
resource use and health outcome measures will provide 
the basis for the evaluation over the trial follow- up 
period. With respect to costing, a publicly funded health 
service perspective will be adopted. That is, resource use 
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associated with delivery of the proposed intervention 
will be measured and costed, as will other health service 
resource use by patients over the course of the trial. For 
the cost utility analysis, effectiveness will be evaluated in 
terms of quality- adjusted life years (QALYs), which will be 
estimated based on responses to the EuroQol EQ- 5D- 5L 
instrument.35
An incremental analysis will be undertaken to provide 
information on the marginal costs and effects of the inter-
vention relative to the control through the calculation of 
incremental cost effectiveness ratios (ICERs).
Probabilistic sensitivity analysis will be performed using 
the range of uncertainties from the statistical analysis of 
the trial. This allows the expected value of perfect infor-
mation (EVPI) to be calculated. In this case, given that 
the data will come from a single trial, this will help to 
inform whether longer follow- up is worth considering 
before investing in the intervention.
A cost- effectiveness acceptability curve (CEAC) will be 
produced to examine the probability of the intervention 
being cost- effective at different cost- effectiveness thresh-
olds. ICER for every QALY gained will be presented along 
with a scatter plot, CEAC and EVPI.
PROCESS EVALUATION
A mixed methods process evaluation is planned and we 
will publish a separate protocol outlining the methods for 
this evaluation, to be submitted to HRB Open Research.
DISCUSSION
This trial will provide some of the most robust results to 
date on link workers. As a recent systematic review on 
link worker interventions concluded, there is insufficient 
evidence ‘to judge either success or value for money’ and 
‘future evaluations must be comparative by design and 
consider when, by whom, for whom, how well and at what 
cost’ interventions are provided.18 While previous proj-
ects have not specified strict inclusion criteria and have 
often focused on younger patients with mental health 
problems,42 we are focusing on multimorbidity, which is 
predicted to increase in prevalence and is known to be 
a particular challenge in areas of deprivation. This will 
contribute to evidence on who is most likely to benefit 
from link workers and social prescribing as well as 
providing robust effectiveness and economic data.
A recent systematic review of the self- management 
characteristics of patients with complex health needs 
concluded that tailored self- management support is 
required for people in areas of socioeconomic depri-
vation to address the social norms that accept poorer 
health, social isolation and socioeconomic insecurity.43 
Link workers are one intervention that could provide this 
kind of support. Governments are recognising this and 
link workers are specifically mentioned in the UK NHS 
Long Term Plan and funding provided to primary care 
clinical commissioning groups for one link worker for 
every 30 000 population.44 An all- party Committee on the 
Future of Healthcare in the Irish Parliament agreed on 
a plan for healthcare reform in Ireland in 2017, called 
Slaintecare.45 This is now being implemented through the 
Department of Health and Children and it emphasises 
a shift towards care in the community and empowering 
people to manage their own health.46 Social prescribing 
is recognised as one way to achieve this. The Department 
of Health announced a Slaintecare Integration Fund 
programme in 2019 which is funding a range of projects 
evaluating interventions that reflect Slaintecare priori-
ties, including this study. Social prescribing is also being 
supported by the Irish national Health Service Executive 
(HSE) with a number of funded pilots.16 17 However, the 
lack of robust evaluation is recognised and the HSE are in 
the process of developing an evaluation framework. The 
results of this trial and process evaluation will be timely 
in informing national policy about the role- out of link 
workers and social prescribing nationally.
Strengths
While there have been a number of smaller trials and 
quasi- experimental studies, this trial will be the first 
large scale pragmatic randomised trial of a link worker 
and social prescribing intervention. This will overcome 
the previous challenge of finding suitable controls in 
non- randomised trials19 47 and provide some of the most 
robust results to date on link workers. Furthermore, this 
will be the first multimorbidity trial with a link worker 
type intervention and this intervention addresses the 
challenge of identifying a generic intervention that works 
across all conditions, as recommended in the Cochrane 
review of interventions for multimorbidity.14
Limitations
Our study is restricted to deprived urban areas. Rural 
areas provide unique challenges and have less concen-
trated deprivation, which would affect costs and 
recruitment timelines. While deprivation in Ireland is 
concentrated in urban areas, the results of this trial may 
not be applicable to more rural locations. Due to the 
nature of the funding and the wait list control design, our 
intervention is only 1 month in duration and this may be 
too short a time to both deliver and show a significant 
difference in outcomes. While the intervention period is 
shorter than the Glasgow Deep End Links Worker model, 
it is in keeping with pilot projects in Ireland where link 
workers supported people over a 6–8 week period.42 In 
order to better understand the mechanisms of impact of 
the intervention, we are collecting a range of measures, 
but a lengthy questionnaire may be off- putting to poten-
tial participants, especially those who are most deprived, 
leading to a biased sample. The levels of patient engage-
ment in the pilot study, however, are encouraging and 
the further input from our patient advisory group and 
expert panel of GPs on recruitment strategies and mate-
rials should mitigate against this. The method in which 
participants are selected may result in a selection bias, 
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with GPs selecting participants based on the GPs percep-
tion of psychosocial needs. This is, however. the way such 
an intervention would be implemented in real- world 
clinical practice, and so the trial is designed to be prag-
matic. To better understand why GPs have selected partic-
ipants, they will be asked to document a reason and this 
will be reported to provide greater transparency into the 
selection of participants. Overall, this pragmatic RCT 
will add to the evidence base for link workers and social 
prescribing at a time when there is considerable national 
and international interest in rolling out this intervention 
more widely.
Ethics approval and dissemination
Ethical approval has been granted by the Irish College 
of General Practitioners Ethics Committee. This includes 
a Data Management Plan and Data Impact Assessment 
Form to ensure adherence to General Data Protection 
Regulation and Health Research Regulations.
The end study results will be published in peer- reviewed 
journals and will be open access. A full report will also 
be submitted to funders. The results will also be dissem-
inated to relevant stakeholders and participating GP 
practices. The PPI panel will be consulted on how best to 
disseminate results to people with multimorbidity.
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